Cardiotoxicity Associated With a Low Doses of 5-FU Promotes Morphoquantitative Changes in the Intrinsic Cardiac Nervous System
- PMID: 39864046
- DOI: 10.1007/s12012-024-09958-y
Cardiotoxicity Associated With a Low Doses of 5-FU Promotes Morphoquantitative Changes in the Intrinsic Cardiac Nervous System
Abstract
5-Fluorouracil (5-FU) is a chemotherapeutic that is used to treat solid tumors. However, 5-FU is associated with several side effects, including cardiotoxicity. Considering the importance of the intrinsic cardiac nervous system (ICNS) for the heart and that little is known about effects of 5-FU on this nervous system plexus, the purpose of the present study was to evaluate effects 5-FU at a low dose on the ICNS and oxidative and inflammatory effects in the heart in Wistar rats. The rats were divided into two groups: treated and 5-FU (n = 6/group). The control group received saline only. The treated group received the following clinical doses of 5-FU: 15 mg/kg for 4 consecutive days, followed by 6 mg/kg for 4 days alternated with non-treatment days, and finally 15 mg/kg as the last dose on day 14. On day 15, the rats were euthanized and underwent thoracotomy. The atria were used for histological analysis, and the ventricles were used for biochemical analysis. The results showed an increase in neuronal density and a decrease in ganglionic and neuronal area in the ICNS. Furthermore, tissue inflammation was observed, indicated by an increase in proinflammatory factors and the enzymatic activity of myeloperoxidase and n-acetyl-glucosaminidase. Oxidative stress was also observed, confirmed by a reduction of endogenous antioxidant defenses and the presence of lipoperoxidation. Treatment with 5-FU also caused cardiac atrophy and fibrosis. These findings indicate that cardiotoxicity is present with 5-FU treatment and affects the morphometric aspects of the ICNS.
Keywords: Cardiac plexus; Fibrosis; Heart; Inflammation; Neurons; Oxidative stress.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of Interest: The authors have no conflicts of interest to declare that are relevant to the content of this article. Ethical Statement: The animal study protocol was approved by the Committee for Ethical Conduct in the Use of Animals in Experimentation of the State University of Maringa/ Parana—Brazil (CEUA, n° 4422140918).
Similar articles
-
Protective effects of melatonin against 5-fluorouracil-induced cardiotoxicity in rats: A comprehensive evaluation of oxidative, inflammatory, and apoptotic pathways.Toxicol Appl Pharmacol. 2025 Jun;499:117343. doi: 10.1016/j.taap.2025.117343. Epub 2025 Apr 14. Toxicol Appl Pharmacol. 2025. PMID: 40239743
-
Cardioprotective effects of bosentan in 5-fluorouracil-induced cardiotoxicity.Toxicology. 2022 Jan 15;465:153042. doi: 10.1016/j.tox.2021.153042. Epub 2021 Nov 17. Toxicology. 2022. PMID: 34800596
-
Taxifolin Protects Against 5-Fluorouracil-Induced Cardiotoxicity in Mice Through Mitigating Oxidative Stress, Inflammation, and Apoptosis: Possible Involvement of Sirt1/Nrf2/HO-1 Signaling.Cardiovasc Toxicol. 2025 Mar;25(3):455-470. doi: 10.1007/s12012-025-09962-w. Epub 2025 Jan 19. Cardiovasc Toxicol. 2025. PMID: 39827225
-
Fluoropyrimidine-associated cardiotoxicity: revisited.Expert Opin Drug Saf. 2009 Mar;8(2):191-202. doi: 10.1517/14740330902733961. Expert Opin Drug Saf. 2009. PMID: 19309247 Review.
-
Cardiotoxicity of 5-fluorouracil.Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):1-5. doi: 10.2174/187152506775268785. Cardiovasc Hematol Agents Med Chem. 2006. PMID: 16529545 Review.
Cited by
-
Cardioprotective effects of dapagliflozin against the acute cardiotoxic effects of 5-fluorouracil.Front Cardiovasc Med. 2025 Jul 18;12:1633420. doi: 10.3389/fcvm.2025.1633420. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40756601 Free PMC article.
References
-
- Aslam, M. S., Naveed, S., Ahmed, A., Abbas, Z., Gull, I., & Athar, M. A. (2014). Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. Journal of Cancer Therapy, 5, 817–822. https://doi.org/10.4236/jct.2014.58089 - DOI
-
- Jatto, J., Oboh, E., & Ntekim, A. (2017). 5-Fluorouracil induced cardiotoxicity in a young patient with colon cancer: An unusual finding. Journal of Oncology Research and Therapy. https://doi.org/10.29011/2574-710X - DOI
-
- Alnaim, L. (2010). Individualization of 5-fluorouracil in the treatment of colorectal cancer. SRX Pharmacology. https://doi.org/10.3814/2010/352491 - DOI
-
- Arias, J. L. (2008). Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules, 13, 2340–2369. https://doi.org/10.3390/molecules13102340 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials